MiNK Therapeutics (INKT) Accumulated Depreciation (2020 - 2025)
MiNK Therapeutics (INKT) posted Accumulated Depreciation of $612245.0 for Q4 2025, up 16.7% sequentially from $524639.0 in Q4 2024, and up 16.7% YoY from $524639.0 in Q4 2024.
MiNK Therapeutics (INKT) Accumulated Depreciation (2020 - 2025) Analysis & Trends
MiNK Therapeutics has reported Accumulated Depreciation for 6 years, with the latest figure at $612245.0 in Q4 2025.
- Quarterly Accumulated Depreciation rose 16.7% year-over-year to $612245.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $612245.0 (up 16.7% YoY) and the FY2025 annual result came in at $612245.0, up 16.7% from the prior year.
- Accumulated Depreciation rose to $612245.0 in Q4 2025 per INKT's latest filing, from $524639.0 in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $612245.0 in Q4 2025 and troughed at $168605.0 in Q4 2021.
- A 5-year average of $417097.8 and a median of $496000.0 in 2023 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2023 and 2024: Accumulated Depreciation jumped 74.65% in 2023, then advanced 5.77% in 2024.
- Over 5 years, Accumulated Depreciation stood at $168605.0 in 2021, then surged by 68.44% to $284000.0 in 2022, then soared by 74.65% to $496000.0 in 2023, then advanced by 5.77% to $524639.0 in 2024, then rose by 16.7% to $612245.0 in 2025.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $612245.0, $524639.0, and $496000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | MiNK Therapeutics | 60.53 Mn | 60.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 612,245.00 |
| Dec 31, 2024 | 524,639.00 |
| Dec 31, 2023 | 496,000.00 |
| Dec 31, 2022 | 284,000.00 |
| Dec 31, 2021 | 168,605.00 |
| Dec 31, 2020 | 98,160.00 |